Harmony Biosciences Holdings, Inc.
HRMY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001802665
In the last 90 days, Harmony Biosciences Holdings, Inc. insiders filed 0 open-market purchases and 2 sales; 328 institutions reported holding it in 13F filings for Q2 2026, worth $1.97B in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Harmony Biosciences Holdings, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 147 | 182 | +35 |
| Shares | 44.6M | 46.1M | +1.58M (+3.5%) |
| Value | $1.90B | $2.26B | +$355.5M (+18.7%) |
New holders (45)
Institutions that held Harmony Biosciences Holdings, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
Sold out (10)
Institutions that held Harmony Biosciences Holdings, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Perceptive Advisors LLC | 239,258 | $10.2M |
| Polar Asset Management Partners Inc. | 51,600 | $2.20M |
| Mirabella Financial Services LLP | 37,083 | $1.58M |
| Schroder Investment Management Group | 33,469 | $1.43M |
| ExodusPoint Capital Management, LP | 8,936 | $381.0K |
| Winton Group Ltd | 6,932 | $296.0K |
| Rafferty Asset Management, LLC | 6,585 | $281.0K |
| Smith Group Asset Management, LLC | 400 | $17.0K |
| Eaton Vance Management | 366 | $16.0K |
| Signaturefd, LLC | 5 | $0 |